period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.2,0.5,0.7,0,0.5833333333333334,[0],
1,1.3,0.5,0.8,0,0.6153846153846154,[0],The FDA is aware of an emerging shortage in the market. We are actively monitoring the situation and urge manufacturers to report production capacities and potential challenges. Healthcare providers are advised to manage supply judiciously while the issue is under resolution.
2,1.2,0.5,0.7,0,0.5833333333333334,[0],The FDA is actively monitoring the emerging drug shortage situation. Manufacturers and healthcare facilities are encouraged to report any issues with supply and distribution. Cooperation is essential to mitigate impacts and restore market stability.
3,1.5,0.65,0.85,0,0.5666666666666667,[0],The FDA is aware of an emerging shortage and is actively coordinating with manufacturers to address disruptions in supply.
4,1.4,0.0,1.4,0,1.0,"[0, 1]",The FDA is issuing a shortage alert for the affected drug due to emerging supply issues. We encourage manufacturers to increase production capacity and stakeholders to coordinate efforts to mitigate the impact on patients. Please avoid over-purchasing to ensure fair distribution.
5,1.3,0.0,1.3,0,1.0,[0],"The FDA recognizes an emerging shortage in the market, likely exacerbated by recent disruptions in manufacturing. We urge affected manufacturers to report supply projections, and buyers are advised to manage resources wisely. The FDA is prepared to offer facilitation to address potential supply gaps and ensure patient needs are met."
6,1.5,0.0,1.5,0,1.0,[0],The FDA acknowledges an emerging shortage of the specific drug. We are actively monitoring the situation and collaborating with stakeholders to ensure patient needs are met. We encourage manufacturers to report any capacity changes.
7,1.2,0.0,1.2,0,1.0,[0],The FDA is issuing a shortage alert for [medication]. We are aware of supply disruptions and are working with manufacturers to address coordination issues. All stakeholders are encouraged to report any difficulties to facilitate a timely resolution.
8,1.5,0.0,1.5,0,1.0,[0],
9,1.5,0.0,1.5,0,1.0,[0],The FDA is aware of emerging supply disruptions for certain drugs. We encourage manufacturers and healthcare providers to report any specific interruptions or concerns. Coordination efforts are being monitored to facilitate improved supply stability.
